Kaplan–Meier analysis revealed significantly reduced relapse-free survival (RFS) (p < 0.05) in 1023 patients with ERα-positive breast cancer with high survivin expression in tumors as compared to 1023 patients with low survivin expression in tumors. This evidence concerns the gene ESR1 and breast carcinoma.